# Study to Evaluate Safety & Efficacy of d-Amphetamine Transdermal System vs Placebo in Children & Adolescents With ADHD

> **NCT01711021** · PHASE2 · COMPLETED · sponsor: **Noven Pharmaceuticals, Inc.** · enrollment: 110 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** d-Amphetamine Transdermal Patch
- **DRUG:** Placebo patch

## Key facts

- **NCT ID:** NCT01711021
- **Lead sponsor:** Noven Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2023-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01711021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01711021, "Study to Evaluate Safety & Efficacy of d-Amphetamine Transdermal System vs Placebo in Children & Adolescents With ADHD". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01711021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*